Amersfoort, Netherlands

Jan H Van Maarseveen

This inventor holds 1 USPTO granted patent. Top assignee: Solvay Pharmaceuticals, Gmbh. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan H Van Maarseveen. Retrieved from https://idiyas.com/inventor/jan-h-van-maarseveen-nvakd3do

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jan H Van Maarseveen: Innovator in Pharmaceutical Chemistry

Introduction

Jan H Van Maarseveen is a notable inventor based in Amersfoort, Netherlands. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic potential.

Latest Patents

Jan H Van Maarseveen holds a patent for "Piperazinophenyl- and piperazinophenyloxycarboxylic acid derivatives." This patent focuses on compounds that exhibit fibrinogen receptor-antagonistic activity, which are crucial in various medical applications.

Career Highlights

Jan is associated with Solvay Pharmaceuticals GmbH, where he has been involved in innovative research and development. His work has contributed to advancements in pharmaceutical formulations and therapeutic agents.

Collaborations

Jan has collaborated with esteemed colleagues such as Wolfgang Kehrbach and Uwe Schoen, enhancing the scope and impact of his research.

Conclusion

Jan H Van Maarseveen's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key figure in the industry. His work continues to influence the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…